Additional Paid in Capital of Moderna, Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
Summary: Moderna, Inc. quarterly Additional Paid in Capital in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
Moderna, Inc. Additional Paid in Capital for the quarter ending 31 Dec 2025 was $1,382,000,000, a 60% increase year-over-year.
Source SEC data: View on sec.gov

Additional Paid in Capital, Quarterly (USD)

Additional Paid in Capital, YoY Quarterly Change (%)

Moderna, Inc. Quarterly Additional Paid in Capital (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$1,382,000,000	+$516,000,000	+60%	31 Dec 2025	10-K	20 Feb 2026	2025	FY
Q3 2025	$1,254,000,000	+$503,000,000	+67%	30 Sep 2025	10-Q	06 Nov 2025	2025	Q3
Q2 2025	$1,127,000,000	+$496,000,000	+79%	30 Jun 2025	10-Q	01 Aug 2025	2025	Q2
Q1 2025	$982,000,000	+$495,000,000	+102%	31 Mar 2025	10-Q	01 May 2025	2025	Q1
Q4 2024	$866,000,000	+$495,000,000	+133%	31 Dec 2024	10-K	20 Feb 2026	2025	FY
Q3 2024	$751,000,000	+$474,000,000	+171%	30 Sep 2024	10-Q	07 Nov 2024	2024	Q3
Q2 2024	$631,000,000	+$438,000,000	+227%	30 Jun 2024	10-Q	01 Aug 2024	2024	Q2
Q1 2024	$487,000,000	-$244,000,000	-33%	31 Mar 2024	10-Q	02 May 2024	2024	Q1
Q4 2023	$371,000,000	-$802,000,000	-68%	31 Dec 2023	10-K	21 Feb 2025	2024	FY
Q3 2023	$277,000,000	-$1,211,000,000	-81%	30 Sep 2023	10-Q	03 Nov 2023	2023	Q3
Q2 2023	$193,000,000	-$2,220,000,000	-92%	30 Jun 2023	10-Q	03 Aug 2023	2023	Q2
Q1 2023	$731,000,000	-$2,913,000,000	-80%	31 Mar 2023	10-Q	04 May 2023	2023	Q1
Q4 2022	$1,173,000,000	-$3,038,000,000	-72%	31 Dec 2022	10-K	23 Feb 2024	2023	FY
Q3 2022	$1,488,000,000	-$3,515,000,000	-70%	30 Sep 2022	10-Q	03 Nov 2022	2022	Q3
Q2 2022	$2,413,000,000	-$2,518,000,000	-51%	30 Jun 2022	10-Q	03 Aug 2022	2022	Q2
Q1 2022	$3,644,000,000	-$1,216,000,000	-25%	31 Mar 2022	10-Q	04 May 2022	2022	Q1
Q4 2021	$4,211,000,000	-$591,000,000	-12%	31 Dec 2021	10-K	24 Feb 2023	2022	FY
Q3 2021	$5,003,000,000	+$276,993,000	+5.9%	30 Sep 2021	10-Q	04 Nov 2021	2021	Q3
Q2 2021	$4,931,000,000	+$255,013,000	+5.5%	30 Jun 2021	10-Q	05 Aug 2021	2021	Q2
Q1 2021	$4,860,000,000	+$1,592,352,000	+49%	31 Mar 2021	10-Q	06 May 2021	2021	Q1
Q4 2020	$4,802,000,000	+$2,132,574,000	+80%	31 Dec 2020	10-K	25 Feb 2022	2021	FY
Q3 2020	$4,726,007,000	+$2,107,515,000	+80%	30 Sep 2020	10-Q	30 Oct 2020	2020	Q3
Q2 2020	$4,675,987,000	+$2,093,853,000	+81%	30 Jun 2020	10-Q	06 Aug 2020	2020	Q2
Q1 2020	$3,267,648,000	+$710,939,000	+28%	31 Mar 2020	10-Q	07 May 2020	2020	Q1
Q4 2019	$2,669,426,000	+$131,271,000	+5.2%	31 Dec 2019	10-K	26 Feb 2021	2020	FY
Q3 2019	$2,618,492,000			30 Sep 2019	10-Q	06 Nov 2019	2019	Q3
Q2 2019	$2,582,134,000			30 Jun 2019	10-Q	08 Aug 2019	2019	Q2
Q1 2019	$2,556,709,000			31 Mar 2019	10-Q	09 May 2019	2019	Q1
Q4 2018	$2,538,155,000	+$2,466,476,000	+3441%	31 Dec 2018	10-K	27 Feb 2020	2019	FY
Q4 2017	$71,679,000			31 Dec 2017	10-K	13 Mar 2019	2018	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.